Valiant Laboratories Limited (VALIANTLAB.BO)
INR 89.6
(-1.88%)
INR 89.6
(-1.88%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 100.15 Million INR | -23.21% |
| 2022 | 130.42 Million INR | -17.48% |
| 2021 | 158.04 Million INR | 160.23% |
| 2020 | 60.73 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q4 | 100.15 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 100.15 Million INR | -23.21% |
| 2023 Q2 | 232.72 Million INR | 0.0% |
| 2022 Q4 | 130.42 Million INR | 0.0% |
| 2022 FY | 130.42 Million INR | -17.48% |
| 2021 FY | 158.04 Million INR | 160.23% |
| 2020 FY | 60.73 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Achyut Healthcare Limited | 568 Thousand INR | -17532.746% |
| Ajanta Pharma Limited | 8.28 Billion INR | 98.791% |
| Alkem Laboratories Limited | 26.61 Billion INR | 99.624% |
| Alpa Laboratories Limited | 136.65 Million INR | 26.709% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 99.391% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 95.605% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.898% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 93.047% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 91.544% |
| Divi's Laboratories Limited | 31.84 Billion INR | 99.685% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 99.842% |
| Eris Lifesciences Limited | 1.89 Billion INR | 94.702% |
| FDC Limited | 3.88 Billion INR | 97.425% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 99.601% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 98.498% |
| Granules India Limited | 13 Billion INR | 99.23% |
| Hester Biosciences Limited | 755.81 Million INR | 86.749% |
| Indoco Remedies Limited | 3.53 Billion INR | 97.163% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | 4.229% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | 33.217% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -2.236% |
| Lasa Supergenerics Limited | 190.43 Million INR | 47.408% |
| Lupin Limited | 49.53 Billion INR | 99.798% |
| Mankind Pharma Limited | 15.53 Billion INR | 99.355% |
| Medicamen Biotech Limited | 593.75 Million INR | 83.132% |
| Medico Remedies Limited | 163.37 Million INR | 38.696% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 98.57% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 90.821% |
| Piramal Pharma Limited | 21.75 Billion INR | 99.54% |
| RPG Life Sciences Limited | 1.01 Billion INR | 90.084% |
| Sigachi Industries Limited | 707.2 Million INR | 85.838% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.899% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 95.668% |
| Syncom Formulations (India) Limited | 210.81 Million INR | 52.492% |
| Unichem Laboratories Limited | 7.04 Billion INR | 98.579% |
| Wanbury Limited | 360.23 Million INR | 72.197% |
| Windlas Biotech Limited | 621.89 Million INR | 83.895% |
| ZIM Laboratories Limited | 812.62 Million INR | 87.675% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 99.709% |
| Brooks Laboratories Limited | 96.1 Million INR | -4.21% |
| Gufic Biosciences Limited | 2 Billion INR | 95.004% |
| Laurus Labs Limited | 18.45 Billion INR | 99.457% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Amrutanjan Health Care Limited | 289.04 Million INR | 65.35% |
| Bal Pharma Limited | 878.11 Million INR | 88.594% |
| Strides Pharma Science Limited | 11.26 Billion INR | 99.111% |
| Venus Remedies Limited | 1.21 Billion INR | 91.77% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 98.442% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 98.588% |
| Shilpa Medicare Limited | 3.44 Billion INR | 97.096% |
| Aarti Drugs Limited | 4.85 Billion INR | 97.939% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 97.643% |
| Suven Life Sciences Limited | 7.08 Million INR | -1313.606% |
| Ind-Swift Limited | 640.91 Million INR | 84.373% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 98.007% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 97.216% |
| Themis Medicare Limited | 705.74 Million INR | 85.809% |
| Ipca Laboratories Limited | 24.71 Billion INR | 99.595% |
| Hikal Limited | 3.03 Billion INR | 96.702% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 99.561% |
| Sequent Scientific Limited | 3.46 Billion INR | 97.107% |
| Novartis India Limited | 448.6 Million INR | 77.674% |
| Wockhardt Limited | 6.4 Billion INR | 98.435% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 99.223% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -292.807% |
| Neuland Laboratories Limited | 3.5 Billion INR | 97.142% |
| Morepen Laboratories Limited | 2.48 Billion INR | 95.971% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -151.138% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 91.9% |